Patent: 5,395,760
✉ Email this page to a colleague
Summary for Patent: 5,395,760
| Title: | DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors |
| Abstract: | Tumor necrosis factor receptor proteins, DNAs and expression vectors encoding TNF receptors, and processes for producing TNF receptors as products of recombinant cell culture, are disclosed. |
| Inventor(s): | Smith; Craig A. (Seattle, WA), Goodwin; Raymond G. (Seattle, WA), Beckmann; M. Patricia (Poulsbo, WA) |
| Assignee: | Immunex Corporation (Seattle, WA) |
| Application Number: | 07/523,635 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,395,760
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | November 02, 1998 | 5,395,760 | 2010-05-10 |
| Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | May 27, 1999 | 5,395,760 | 2010-05-10 |
| Immunex Corporation | ENBREL | etanercept | Injection | 103795 | September 27, 2004 | 5,395,760 | 2010-05-10 |
| Immunex Corporation | ENBREL | etanercept | Injection | 103795 | February 01, 2007 | 5,395,760 | 2010-05-10 |
| Immunex Corporation | ENBREL MINI | etanercept | Injection | 103795 | September 14, 2017 | 5,395,760 | 2010-05-10 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,395,760
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 907072 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 9103553 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 9319777 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 9406476 | ⤷ Start Trial |
| United States of America | 2002006391 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
